checkmate 9er: what is the impact for rcc?
Published 6 months ago • 148 plays • Length 5:05
Download video MP4
Download video MP3
Similar videos
-
3:35
checkmate-9er discussion: depth of response with first-line cabozantinib/nivolumab
-
8:33
keynote-564, checkmate 9er, and more: where do we stand with advanced and metastatic rcc?
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
7:05
checkmate 9er: frontline nivolumab/cabozantinib in rcc patients with metastases, qol considerations
-
4:35
checkmate 8y8 trial in progress: what are the implications for this doublet?
-
11:13
for patients: how cabometyx® (cabozantinib) may work
-
3:41
a physician faces stage iv #kidneycancer: his advice for you
-
9:51
kidney cancer survivor story | rachel rhee | the patient story
-
5:33
checkmate 67t and the potential of subcutaneous nivolumab administration
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
1:35
checkmate-9er shows efficacy of nivolumab/cabozantinib combo in rcc
-
1:58
checkmate-9er proves to be efficacious in advanced or metastatic rcc
-
2:38
checkmate 9er: cabo-nivo superior to sunitinib in extended follow-up results
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
4:01
checkmate 9er trial: nivo cab vs sun 1l in advanced rcc
-
1:56
checkmate 9er: arcc patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib
-
7:28
rcc panel reacts to long-term follow-up from checkmate 214
-
6:17
in rcc, what is the optimal treatment for intermediate/poor-risk disease?
-
1:33
eleni efstathiou, md, phd, offers opinion on whether checkmate 9er is practice-changing
-
5:21
jorge a. garcia, md, summarizes the significance of checkmate 9er from asco gu 2021
-
2:01
checkmate 9er trial demonstrates efficacy in patients with rcc
-
2:02
eleni efstathiou, md, phd, discusses the checkmate 9er clinical trial presented at esmo 2020
Clip.africa.com - Privacy-policy